COVID-19 vaccination and rheumatological manifestations: RS3PE syndrome?
Rheumatology (Bulgaria) · 10.02.2026 · 33 (3) · 55-57
DOI: 10.35465/rbj.rbj.128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology (Bulgaria), online erschienen am 10.02.2026. Verfasst von Tiago Borges und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Rheumatological manifestations of SARS-CoV-2 infection and COVID-19 vaccination are being repeatedly reported. Herein, we describe a case of a 75-year-old woman who presented with pitting edema of hands and feet and arthritis of small joints following the administration of BNT162b2 (BioNTech-Pfizer) mRNA vaccine. We also discuss potential mechanisms that might explain the occurrence of RS3PE as a rheumatological manifestation of COVID-19 vaccination.
Zitieren
APA
Borges, T., & Silva, S. (2026). COVID-19 vaccination and rheumatological manifestations: RS3PE syndrome?. Rheumatology (Bulgaria), 33(3), 55-57. https://doi.org/10.35465/rbj.rbj.128
Vancouver
Borges T, Silva S. COVID-19 vaccination and rheumatological manifestations: RS3PE syndrome?. Rheumatology (Bulgaria). 2026;33(3):55-57. doi:10.35465/rbj.rbj.128
BibTeX
@article{Borges2026,
author = {Borges, Tiago and Silva, Sérgio},
title = {COVID-19 vaccination and rheumatological manifestations: RS3PE syndrome?},
journal = {Rheumatology (Bulgaria)},
year = {2026},
volume = {33},
number = {3},
pages = {55--57},
doi = {10.35465/rbj.rbj.128}
}
EUVIMED